Cargando…

Hetero-pentamerization determines mobility and conductance of Glycine receptor α3 splice variants

Glycine receptors (GlyRs) are ligand-gated pentameric chloride channels in the central nervous system. GlyR-α3 is a possible target for chronic pain treatment and temporal lobe epilepsy. Alternative splicing into K or L variants determines the subcellular fate and function of GlyR-α3, yet it remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemmens, Veerle, Thevelein, Bart, Vella, Yana, Kankowski, Svenja, Leonhard, Julia, Mizuno, Hideaki, Rocha, Susana, Brône, Bert, Meier, Jochen C., Hendrix, Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534812/
https://www.ncbi.nlm.nih.gov/pubmed/36197517
http://dx.doi.org/10.1007/s00018-022-04506-9
Descripción
Sumario:Glycine receptors (GlyRs) are ligand-gated pentameric chloride channels in the central nervous system. GlyR-α3 is a possible target for chronic pain treatment and temporal lobe epilepsy. Alternative splicing into K or L variants determines the subcellular fate and function of GlyR-α3, yet it remains to be shown whether its different splice variants can functionally co-assemble, and what the properties of such heteropentamers would be. Here, we subjected GlyR-α3 to a combined fluorescence microscopy and electrophysiology analysis. We employ masked Pearson’s and dual-color spatiotemporal correlation analysis to prove that GlyR-α3 splice variants heteropentamerize, adopting the mobility of the K variant. Fluorescence-based single-subunit counting experiments revealed a variable and concentration ratio dependent hetero-stoichiometry. Via cell-attached single-channel electrophysiology we show that heteropentamers exhibit currents in between those of K and L variants. Our data are compatible with a model where α3 heteropentamerization fine-tunes mobility and activity of GlyR-α3 channels, which is important to understand and tackle α3 related diseases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04506-9.